Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. (Q50535464)

15 March 2018

title

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. (English)

1 reference

15 March 2018

main subject

myocardial infarction

1 reference

1 reference

Garratt KN

1

1 reference

15 March 2018

Brady PA

2

1 reference

15 March 2018

Hassinger NL

3

1 reference

15 March 2018

Grill DE

4

1 reference

15 March 2018

Terzic A

5

1 reference

15 March 2018

Holmes DR Jr

6

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

15 March 2018

Journal of the American College of Cardiology

published in

1 reference

15 March 2018

volume

33

1 reference

15 March 2018

page(s)

119-124

1 reference

15 March 2018

issue

1

1 reference

15 March 2018

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Myocardial infarction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Prevalence and mortality of acute myocardial infarction in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

The sulfonylurea controversy: more questions from the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Sulfonylurea receptors and mechanism of sulfonylurea action

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

The pharmacology of ATP-sensitive potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

The sulfonylurea receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Glibenclamide specifically blocks ATP-sensitive K+ channel current in atrial myocytes of guinea pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

ATP-sensitive potassium channels and myocardial preconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Beta 2-adrenergic dilation of resistance coronary vessels involves KATP channels and nitric oxide in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2+ loading in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Late outcome after percutaneous transluminal coronary angioplasty during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Plasminogen activator inhibitor-1 in nonobese subjects with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900557-9

7 January 2021

10.1016/S0735-1097(98)00557-9

Identifiers

DOI

1 reference

15 March 2018

release_dcevtflquvg4fpj7cyqae7jgiy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dcevtflquvg4fpj7cyqae7jgiy

24 November 2022

mapped directly with Wikidata item

PubMed ID

9935017

1 reference

15 March 2018